174 related articles for article (PubMed ID: 27071853)
1. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.
Bonvicini F; Bua G; Manaresi E; Gallinella G
Virus Res; 2016 Jul; 220():47-51. PubMed ID: 27071853
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effect of cidofovir on parvovirus B19 replication.
Bonvicini F; Bua G; Manaresi E; Gallinella G
Antiviral Res; 2015 Jan; 113():11-8. PubMed ID: 25446336
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of brincidofovir on parvovirus B19.
Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.
Ning K; Roy A; Cheng F; Xu P; Kleiboeker S; Escalante CR; Wang J; Qiu J
J Virol; 2022 Jan; 96(2):e0132621. PubMed ID: 34669461
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.
Bonvicini F; Bua G; Conti I; Manaresi E; Gallinella G
Biochem Pharmacol; 2017 Jul; 136():32-39. PubMed ID: 28377277
[TBL] [Abstract][Full Text] [Related]
6. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
[TBL] [Abstract][Full Text] [Related]
7. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.
Chen AY; Guan W; Lou S; Liu Z; Kleiboeker S; Qiu J
J Virol; 2010 Dec; 84(23):12385-96. PubMed ID: 20861249
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Replication and Infection of Human Parvovirus B19.
Ganaie SS; Qiu J
Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
[TBL] [Abstract][Full Text] [Related]
9. Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development.
Xu P; Ganaie SS; Wang X; Wang Z; Kleiboeker S; Horton NC; Heier RF; Meyers MJ; Tavis JE; Qiu J
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530599
[TBL] [Abstract][Full Text] [Related]
10. Advances in the Development of Antiviral Strategies against Parvovirus B19.
Manaresi E; Gallinella G
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323869
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.
Wong S; Zhi N; Filippone C; Keyvanfar K; Kajigaya S; Brown KE; Young NS
J Virol; 2008 Mar; 82(5):2470-6. PubMed ID: 18160440
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.
Bua G; Manaresi E; Bonvicini F; Gallinella G
PLoS One; 2016; 11(2):e0148547. PubMed ID: 26845771
[TBL] [Abstract][Full Text] [Related]
13. RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers.
Wang J; Ganaie SS; Cheng F; Xu P; Ning K; Wang X; Kleiboeker S; Cheng S; Qiu J
mBio; 2020 Mar; 11(2):. PubMed ID: 32156816
[TBL] [Abstract][Full Text] [Related]
14. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.
Luo Y; Kleiboeker S; Deng X; Qiu J
J Virol; 2013 Dec; 87(23):12766-75. PubMed ID: 24049177
[TBL] [Abstract][Full Text] [Related]
15. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα.
Chen AY; Kleiboeker S; Qiu J
PLoS Pathog; 2011 Jun; 7(6):e1002088. PubMed ID: 21698228
[TBL] [Abstract][Full Text] [Related]
16. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions.
Bua G; Tedesco D; Conti I; Reggiani A; Bartolini M; Gallinella G
Viruses; 2020 Aug; 12(9):. PubMed ID: 32854437
[TBL] [Abstract][Full Text] [Related]
17. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
Wolfisberg R; Ruprecht N; Kempf C; Ros C
J Virol Methods; 2013 Oct; 193(1):215-25. PubMed ID: 23764418
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
Chamberlain JM; Sortino K; Sethna P; Bae A; Lanier R; Bambara RA; Dewhurst S
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397065
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex.
Ganaie SS; Zou W; Xu P; Deng X; Kleiboeker S; Qiu J
PLoS Pathog; 2017 May; 13(5):e1006370. PubMed ID: 28459842
[TBL] [Abstract][Full Text] [Related]
20. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.
Adamson-Small LA; Ignatovich IV; Laemmerhirt MG; Hobbs JA
Virus Res; 2014 Sep; 190():8-16. PubMed ID: 24998884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]